Dupilumab in persistent asthma.
Nina H
NH
Bjarnason
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D004802:Eosinophilia / Q000150:complications*; D005260:Female; D006801:Humans; D053662:Interleukin-4 Receptor alpha Subunit / Q000276:immunology*; D008297:Male
D018927:Anti-Asthmatic Agents; D000911:Antibodies, Monoclonal; D053662:Interleukin-4 Receptor alpha Subunit